Speeding Up Coagulation Tests: How Rapid Centrifugation Can Save Time and Improve Patient Care
"Discover how a faster centrifugation technique for PT and APTT testing can significantly reduce turnaround time, benefiting critical care and outpatient settings."
In healthcare, time is of the essence, especially when dealing with patients who have coagulation disorders or are undergoing anticoagulation therapy. Prothrombin Time (PT) and activated partial thromboplastin time (APTT) tests are crucial for monitoring these patients, but the traditional methods can be time-consuming.
One of the most significant bottlenecks in coagulation testing is sample processing, specifically centrifugation. Traditional centrifugation can take 15-30 minutes, delaying treatment and increasing the overall turnaround time (TAT) for results. This delay can be particularly problematic in critical care settings, emergency rooms, and operating theaters where quick decisions are vital.
But what if there was a way to speed up this process without compromising the accuracy of the results? Research has explored the use of rapid centrifugation techniques to reduce TAT for PT and APTT testing. This article delves into a study comparing rapid centrifugation with conventional methods, highlighting the potential benefits for both patients and healthcare providers.
Current Evidence on Rapid Centrifugation
Coagulation assays typically use standard centrifugation at 1500 g for 15 minutes, while chemistry samples may use a rapid protocol of 2300 g for 5 minutes. A multianalyzer study evaluated whether rapid centrifugation affected prothrombin time (PT), activated partial thromboplastin time (APTT), and D-dimer results, with the broader aim of supporting harmonized workflows and total laboratory automation. Another comparison found strong analytical agreement when a 10-minute, 3200 g routine method was compared with a 5-minute, 4000 g method across chemistry, immunochemistry, coagulation, and interference indices.
Standard Processing and Turnaround Constraints
Centrifugation is a critical sample-processing step in coagulation testing because it can affect turnaround time, as shown in a study of 300 paired samples submitted for PT and APTT testing. A report summarized a comparison between standard centrifugation at 4000 rpm for 15 minutes and rapid protocols; it stated that 4000 rpm for 10 minutes produced platelet-poor plasma in 100% of samples without significant differences in PT, APTT, or fibrinogen results. Separate research examined whether routine coagulation results remained comparable when Becton Dickinson Vacutainer Citrate Plus tubes were filled to minimum or optimal volume, highlighting tube filling as another processing consideration.
From Bottleneck to Automation
Centrifugation has long been recognized as a crucial part of the coagulation pre-analytical phase. A 2019 review described it as a potential bottleneck in total laboratory automation workflows. More recent work reports that rapid centrifugation can produce coagulation results comparable to standard methods while supporting laboratory efficiency and integration with total laboratory automation.
Rapid Centrifugation: A Faster Approach to Coagulation Testing
A recent study published in the Indian Journal of Hematology and Blood Transfusion investigated whether a rapid centrifugation technique could provide comparable results to conventional centrifugation for PT and APTT testing. The study involved 300 paired samples from patients requiring PT and APTT estimations. One sample from each patient was processed using a regular benchtop centrifuge at 1500g for 20 minutes, while the other was divided into two aliquots and centrifuged in a microcentrifuge at 13000g for just 3 minutes.
- Comparing PT, INR, and APTT values obtained from both centrifugation methods.
- Assessing the correlation between the two methods.
- Evaluating the agreement between the methods using Bland-Altman plots.
- Analyzing INR values across different therapeutic ranges.
Emerging Evidence
Recent work suggests that rapid centrifugation may shorten coagulation-sample processing without necessarily compromising commonly measured results. However, the evidence described here is best viewed as supportive rather than definitive because protocols, analyzers, and evaluated assays differ. Wider adoption would therefore require validation under each laboratory's specific operating conditions.
Remaining Risks
Rapid centrifugation should not be treated as automatically interchangeable with every standard protocol. Differences in centrifugation speed, duration, tube filling, analyzers, and assay types may influence whether results remain comparable. Laboratories may therefore need local verification before changing established workflows.
Comparing Processing Strategies
Comparisons of centrifugation methods generally focus on whether shorter processing can preserve analytical performance. The available evidence points toward potential agreement in many settings, but it does not establish one universal speed-and-time combination for all coagulation laboratories. Meaningful comparison requires attention to the sample type, assay, instrument, and validation design.
The Implications of Faster Turnaround Times
The study's findings suggest that rapid centrifugation is a safe and effective alternative to conventional centrifugation for routine coagulation testing. By reducing the centrifugation time from 20 minutes to just 3 minutes, laboratories can significantly decrease the overall turnaround time for PT and APTT results.
What the Evidence Suggests
Taken together, the available material supports rapid centrifugation as a promising way to address a pre-analytical bottleneck in coagulation testing. Its value depends on maintaining result comparability while reducing processing time. The most defensible implementation is evidence-based and locally validated rather than based on speed alone.
Toward Faster Automation
Future development is likely to center on harmonized centrifugation protocols that can be incorporated into total laboratory automation. Rapid processing may help laboratories coordinate coagulation testing more efficiently with other automated sample workflows. Further studies will be needed to determine how consistently these approaches perform across analyzers, assays, and clinical settings.
Beyond the Centrifuge
Centrifugation is only one part of the broader pre-analytical pathway, so faster spinning alone may not remove every source of delay. Workflow design, tube handling, sample quality, and instrument compatibility can all affect the final turnaround process. System-wide improvement therefore requires harmonization rather than an isolated change to centrifugation time.
Improving Care Through Workflow
A shorter sample-processing step could help laboratories return coagulation results more efficiently, which may support faster clinical decision-making. The practical benefit depends on preserving reliable PT, APTT, D-dimer, and other assay results while fitting the laboratory's existing workflow. Careful validation remains important because patient-care gains are meaningful only when speed and analytical quality are maintained together.
This reduction in TAT can have several important benefits, particularly in critical care settings where timely results are crucial for guiding treatment decisions. Faster results can lead to quicker diagnoses, more prompt initiation of therapy, and ultimately, improved patient outcomes. Additionally, reducing TAT can also benefit outpatients undergoing oral anticoagulant therapy, minimizing waiting times and improving their overall experience.
While this study focused on PT and APTT testing, the principles of rapid centrifugation could potentially be applied to other coagulation assays, further streamlining laboratory workflows and enhancing patient care. Further research may explore these implications.